GlassScriptPhysician profile
Robert Elliot Browning
NPI 1053809566
$3,827.79
in general payments reported to CMS, 2019-2025
14 companies · $904 in 2025
The $904 reported for 2025 was more than what 75% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $876 · 2023: $1,481 · 2024: $566 · 2025: $904.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,952.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,951.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,123.01 | 2022-2025 | Xen Glaucoma Treatment System, Durysta |
| Sight Sciences, INC. | $1,109.76 | 2022-2025 | Omni Surgical System, Sion Surgical Instrument |
| Glaukos Corporation | $559.66 | 2022-2025 | Photrexa Viscous and Photrexa, Idose, Idosetr |
| Alcon Vision LLC | $325.08 | 2023-2025 | Clareon, Total30, Hydrus Microstent |
| Bausch & Lomb Americas INC. | $284.70 | 2022-2025 | Miebo, Xiidra |
| Johnson & Johnson Surgical Vision, INC. | $110.37 | 2023-2025 | Tecnis Simplicity |
| Mallinckrodt Hospital Products INC. | $92.02 | 2022-2025 | Acthar |
| Nova Eye, INC. | $75.48 | 2024 | |
| Thea Pharma INC. | $42.89 | 2024-2025 | Iyuzeh |
| Carl Zeiss Meditec Cataract Technology INC. | $32.30 | 2022 | |
| Rayner Intraocular Lenses Limited | $22.20 | 2023 | Rayone Spheric, Omidria, Rayone Emv |
| Biotissue Holdings INC. | $17.50 | 2025 | |
| Sun Pharmaceutical Industries INC. | $17.50 | 2023 | Cequa |
| Glaxosmithkline, LLC. | $15.32 | 2025 | Arexvy, Trelegy Ellipta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Browning listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.